首页
数据库
关于我们
联系我们
您当前的位置： 首页 > 数据库
所属年份
2008 2017 2018 2019 2020 2021 2022 2023 2024
到
2008 2017 2018 2019 2020 2021 2022 2023 2024
检索 清除
手术分类
  • 全部（1880）
  • 腹部手术（323）
  • 胸科手术（41）
  • 血管手术（5）
  • 心脏手术（56）
  • 神经外科（4）
  • 头颈部（35）
  • 骨科（78）
  • 泌尿外科（0）
  • 妇产手术（56）
  • 日间手术（26）
  • 手术室外（0）
  • 创伤和烧伤（0）
  • 非心脏手术（410）
  • 老年（0）
  • 小儿新生儿（126）
  • 特殊患者（42）
  • 未说明手术类型（678）
阶段管理
  • 术前宣教（21）
  • 术前评估（33）
  • 术前用药（15）
  • 术前禁食水（12）
  • 麻醉选择（21）
  • 麻醉用药（10）
  • 术中监测（23）
  • 液体管理（14）
  • 血液保护（3）
  • 体温管理（8）
  • 术后疼痛（43）
  • POD（8）
  • PONV（10）
  • 术后康复（50）
  • 特殊情况（43）
  • 术前肠道准备（9）
排序：
发表时间 阅读量
Array ( [id] => 1338 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1338.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients undergoing liver transplantation, VHA monitoring with assessment of fibrinogen is recommended for guiding fibrinogen replacement.（Evidence level: low；Recommendation grade:strong） [laiyuan] => 在接受肝移植的患者中，建议监测黏弹性止血试验并评估纤维蛋白原，以指导纤维蛋白原的替代。（证据级别：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
在接受肝移植的患者中，建议监测黏弹性止血试验并评估纤维蛋白原，以指导纤维蛋白原的替代。（证据级别：低；推荐强度：强推荐）

In patients undergoing liver transplantation, VHA monitoring with assessment of fibrinogen is recommended for guiding fibrinogen replacement.（Evidence level: low；Recommendation grade:strong）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1339 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1339.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In postoperative liver transplant patients, VHA with fibrinogen assessment may be considered for postoperative monitoring of coagulation together with VHAguided use of coagulation factors and/or blood products. （Evidence level: low；Recommendation grade: weak） [laiyuan] => 肝移植术后可考虑采用VHA联合纤维蛋白原检测进行术后凝血功能监测，并指导凝血因子和(或)血液制品的使用。（证据级别：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
肝移植术后可考虑采用VHA联合纤维蛋白原检测进行术后凝血功能监测，并指导凝血因子和(或)血液制品的使用。（证据级别：低；推荐强度：弱推荐）

In postoperative liver transplant patients, VHA with fibrinogen assessment may be considered for postoperative monitoring of coagulation together with VHAguided use of coagulation factors and/or blood products. （Evidence level: low；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1340 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1340.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We recommend TXA for treatment of fibrinolysis in OLT but not for routine prophylaxis; marginal grafts (donation after cardiac death) increase the risk of fibrinolysis postreperfusion.（Evidence level: low；Recommendation grade:strong） [laiyuan] => 我们推荐TXA用于肝移植纤溶治疗，但不推荐用于常规预防;边缘移植物(心脏死亡后器官捐献)增加了再灌注后纤溶的风险。（证据级别：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
我们推荐TXA用于肝移植纤溶治疗，但不推荐用于常规预防;边缘移植物(心脏死亡后器官捐献)增加了再灌注后纤溶的风险。（证据级别：低；推荐强度：强推荐）

We recommend TXA for treatment of fibrinolysis in OLT but not for routine prophylaxis; marginal grafts (donation after cardiac death) increase the risk of fibrinolysis postreperfusion.（Evidence level: low；Recommendation grade:strong）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1341 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1341.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => PCC administration in low doses guided by VHA (prolonged coagulation initiation or increased INR if no VHA available) is suggested in the presence of clinically significant bleeding in patients without fibrinogen deficiency.（Evidence level: low；Recommendation grade:weak） [laiyuan] => 建议在没有纤维蛋白原缺乏的患者存在临床显著出血的情况下，在粘弹性止血试验指导下低剂量给予凝血酶原复合物浓缩物(如果没有粘弹性止血试验，则延长凝血起始时间或增加INR)。（证据级别：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
建议在没有纤维蛋白原缺乏的患者存在临床显著出血的情况下，在粘弹性止血试验指导下低剂量给予凝血酶原复合物浓缩物(如果没有粘弹性止血试验，则延长凝血起始时间或增加INR)。（证据级别：低；推荐强度：弱推荐）

PCC administration in low doses guided by VHA (prolonged coagulation initiation or increased INR if no VHA available) is suggested in the presence of clinically significant bleeding in patients without fibrinogen deficiency.（Evidence level: low；Recommendation grade:weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1342 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1342.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In liver transplant, fibrinogen concentrate use should be restricted only to patients with documented hypofi-brinogenaemia (by standard coagulation tests or VHA). （Evidence level: low；Recommendation grade: strong） [laiyuan] => 在肝移植中，纤维蛋白原浓缩物的使用应仅限于有低纤维蛋白原血症记录的患者(通过标准凝血试验或VHA)。（证据级别：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
在肝移植中，纤维蛋白原浓缩物的使用应仅限于有低纤维蛋白原血症记录的患者(通过标准凝血试验或VHA)。（证据级别：低；推荐强度：强推荐）

In liver transplant, fibrinogen concentrate use should be restricted only to patients with documented hypofi-brinogenaemia (by standard coagulation tests or VHA). （Evidence level: low；Recommendation grade: strong）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1343 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1343.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Preemptive fibrinogen administration before liver transplantation is not recommended. （Evidence level: low；Recommendation grade: strong） [laiyuan] => 不建议在肝移植前预防性使用纤维蛋白原。（证据级别：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
不建议在肝移植前预防性使用纤维蛋白原。（证据级别：低；推荐强度：强推荐）

Preemptive fibrinogen administration before liver transplantation is not recommended. （Evidence level: low；Recommendation grade: strong）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1344 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1344.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => rFVIIa is not recommended for routine use in OLT and should be used only as rescue therapy for uncontrolled bleeding. （Evidence level: low；Recommendation grade: strong） [laiyuan] => rFVIIa不推荐常规用于肝移植，仅可用于未控制出血的补救治疗。（证据级别：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
rFVIIa不推荐常规用于肝移植，仅可用于未控制出血的补救治疗。（证据级别：低；推荐强度：强推荐）

rFVIIa is not recommended for routine use in OLT and should be used only as rescue therapy for uncontrolled bleeding. （Evidence level: low；Recommendation grade: strong）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1345 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1345.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We suggest the use of cell salvage and autotransfusion with leukodepletion filters in liver transplantation includ_x005fing patients with HCC. （Evidence level: low；Recommendation grade: weak） [laiyuan] => 我们建议在肝移植中，包括有HCC的病人，应使用细胞回收和白细胞去除滤器的自体输血。（证据级别：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
我们建议在肝移植中，包括有HCC的病人，应使用细胞回收和白细胞去除滤器的自体输血。（证据级别：低；推荐强度：弱推荐）

We suggest the use of cell salvage and autotransfusion with leukodepletion filters in liver transplantation includ_x005fing patients with HCC. （Evidence level: low；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1346 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1346.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => TXA administered systemically or locally in the irrigant fluid may be considered in order to decrease peri-operative blood loss in percutaneous nephrolithotomy. （Evidence level: moderate；Recommendation grade: weak） [laiyuan] => 在经皮肾镜取石术中，可以考虑全身或局部灌注XA，以减少围手术期出血量。（证据级别：中；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
在经皮肾镜取石术中，可以考虑全身或局部灌注XA，以减少围手术期出血量。（证据级别：中；推荐强度：弱推荐）

TXA administered systemically or locally in the irrigant fluid may be considered in order to decrease peri-operative blood loss in percutaneous nephrolithotomy. （Evidence level: moderate；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1347 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1347.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:30 [updatetime] => 2024-01-11 15:24:30 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => TXA may be considered in order to decrease peri-operative blood loss in prostate surgery. （Evidence level: moderate；Recommendation grade: weak） [laiyuan] => 在前列腺手术中可考虑使用TXA以减少围手术期失血量。（证据级别：中；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957870 [_updatetime] => 1704957870 [_nrjc] => [_nrsh] => )
推荐意见
在前列腺手术中可考虑使用TXA以减少围手术期失血量。（证据级别：中；推荐强度：弱推荐）

TXA may be considered in order to decrease peri-operative blood loss in prostate surgery. （Evidence level: moderate；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读

地址：甘肃省兰州市七里河区瓜州路418号

邮编：730050

电话：0931-2687109

商务合作热线：0931-2687106

备案号：陇ICP备17005383号-1 联网备案号：62010302000288

技术支持：瑞秀科技